CRYSTAL ADKINS: Open Payments
NPI 1962174656 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,181 in 82 payments from 18 companies in 2025. Trend: 2023 $59 · 2024 $258 · 2025 $2,181
Food & beverage: $2,181
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $415 |
| ABBVIE INC. | 9 | $243 |
| Axsome Therapeutics, Inc. | 2 | $235 |
| Teva Pharmaceuticals USA, Inc. | 6 | $219 |
| Neurocrine BioSciences, Inc. | 11 | $157 |
| Biogen, Inc. | 3 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Alkermes, Inc. | 6 | $119 |
| Almatica Pharma LLC | 4 | $96 |
| Lundbeck LLC | 3 | $84 |
Products named: REXULTI, VRAYLAR, Auvelity, AUSTEDO XR, INGREZZA, ZURZUVAE, COBENFY, ARISTADA.
Industry payments across OH — which companies pay providers there.
